Skip to content

Drug interactions

Ospemifene + Ticlopidine

Severity: Moderate

Ospemifene and Ticlopidine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ticlopidine inhibits CYP2C19, and ospemifene is partly metabolized by CYP2C19 along with CYP3A4 and CYP2C9. Ospemifene exposure may therefore increase, raising the risk of adverse effects such as hot flashes or thromboembolic events.

What this interaction means in plain words

Ospemifene and Ticlopidine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ospemifene belongs to Endocrine; Ticlopidine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Ticlopidine inhibits CYP2C19-mediated metabolism of ospemifene.

What to do

Monitor for ospemifene adverse effects, particularly thromboembolic events and endometrial changes. Consider an alternative if clinically significant effects appear.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ospemifene and Ticlopidine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ospemifene with Ticlopidine?

MediHelp rates the interaction as moderate. Ospemifene and Ticlopidine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ticlopidine inhibits CYP2C19, and ospemifene is partly metabolized by CYP2C19 along with CYP3A4 and CYP2C9. Ospemifene exposure may therefore increase, raising the risk of adverse effects such as hot flashes or thromboembolic events.

How serious is the interaction between Ospemifene and Ticlopidine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ospemifene adverse effects, particularly thromboembolic events and endometrial changes. Consider an alternative if clinically significant effects appear.

What other medicines interact with Ticlopidine?

MediHelp also lists interactions of Ticlopidine with, for example, Mavacamten, Abrocitinib, Acetylsalicylic acid. The full list is on the Ticlopidine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in